FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
2.250
+0.220 (10.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
FibroBiologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 7.83 | 9.16 | 2.27 | 0.41 | - |
Cash & Short-Term Investments | 7.83 | 9.16 | 2.27 | 0.41 | - |
Cash Growth | -27.30% | 304.37% | 456.76% | - | - |
Receivables | - | - | 0.3 | - | - |
Prepaid Expenses | 0.35 | 0.04 | 0.03 | 0.04 | - |
Other Current Assets | 0.02 | 0.02 | 0.03 | 0.02 | - |
Total Current Assets | 8.2 | 9.22 | 2.63 | 0.47 | - |
Property, Plant & Equipment | 2.27 | 2.61 | 2.2 | - | - |
Accounts Payable | 1.18 | 1.44 | 0.76 | 0.23 | - |
Short-Term Debt | 0.12 | - | 5.45 | 1.53 | - |
Current Portion of Leases | 0.39 | 0.36 | 0.33 | - | - |
Other Current Liabilities | 4.99 | 7.38 | 0.54 | - | - |
Total Current Liabilities | 6.68 | 9.18 | 7.07 | 1.76 | - |
Long-Term Leases | 1.06 | 1.39 | 1.75 | - | - |
Common Stock | - | 0 | 0 | - | 1.17 |
Additional Paid-In Capital | 35.16 | 25.61 | 2.41 | - | - |
Retained Earnings | -32.42 | -24.36 | -7.87 | -2.75 | -1.17 |
Comprehensive Income & Other | - | - | 1.46 | 1.46 | - |
Total Liabilities & Equity | 10.47 | 11.82 | 4.82 | 0.47 | - |
Total Debt | 1.56 | 1.75 | 7.52 | 1.53 | - |
Net Cash (Debt) | 6.27 | 7.42 | -5.26 | -1.12 | - |
Net Cash Per Share | 0.20 | 0.26 | -0.19 | -0.13 | - |
Filing Date Shares Outstanding | 34.66 | 32.49 | 28.23 | 40.73 | 8.75 |
Total Common Shares Outstanding | 33.92 | 28.23 | 28.23 | 40.73 | 8.75 |
Working Capital | 1.52 | 0.03 | -4.45 | -1.29 | - |
Book Value Per Share | 0.08 | 0.04 | -0.14 | -0.03 | - |
Tangible Book Value | 2.74 | 1.25 | -4 | -1.29 | - |
Tangible Book Value Per Share | 0.08 | 0.04 | -0.14 | -0.03 | - |
Machinery | 0.93 | 0.84 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.